Testing effectiveness (Phase 2)Ended earlyNCT00706992What this trial is testingAnti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma PatientsWho this might be right forMelanoma National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT07226544What this trial is testingIvonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerWho this might be right forLocalized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT04238819What this trial is testingAbemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaWho this might be right forRelapsed Solid TumorRefractory Solid Tumor Eli Lilly and Company 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT06839092What this trial is testingProphylactic PIPAC in Patients With High-risk Colorectal CancerWho this might be right forColorectal Cancer Control and PreventionColorectal CancerColorectal Cancer Stage II+1 more Jeremy Meyer 160
Testing effectiveness (Phase 2)Looking for participantsNCT07238712What this trial is testingOptimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorWho this might be right forAcute Myeloid Leukemia (AML)Chronic Myeloid LeukemiaMyelodysplastic Syndromes (MDS)+2 more St. Petersburg State Pavlov Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT04294277What this trial is testingSafety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical SurgeryWho this might be right forUrothelial Cancer European Association of Urology Research Foundation 2
Testing effectiveness (Phase 2)Looking for participantsNCT06437353What this trial is testingSurufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian CancerWho this might be right forOvarian Cancer Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)UnknownNCT03080116What this trial is testingNeoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical ProstatectomyWho this might be right forProstate CancerNeoadjuvant TherapyAndrogen Antagonists+1 more Universitaire Ziekenhuizen KU Leuven 90
Early research (Phase 1)Study completedNCT01172964What this trial is testingA Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasWho this might be right forAdult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more City of Hope Medical Center 15
Large-scale testing (Phase 3)UnknownNCT06161909What this trial is testingPostoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical ResectionWho this might be right forEsophageal Squamous Cell Carcinoma Thoracic Stage IIEsophageal Squamous Cell Carcinoma Thoracic Stage IIIEsophageal Squamous Cell Carcinoma Thoracic Stage IV Fujian Medical University Union Hospital 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844What this trial is testingBiodistribution and Dosimetry of Ga-68 P16-093 in Prostate CancerWho this might be right forProstate Cancer RecurrentProstate Cancer Five Eleven Pharma, Inc. 60
Not applicableStudy completedNCT07155330What this trial is testingHigh-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea PatientsWho this might be right forHypoxemiaEsophageal CancerGastric Cancer (Diagnosis)+1 more Zhejiang University 80
Testing effectiveness (Phase 2)Study completedNCT00290511What this trial is testingRituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 49
Not applicableNot Yet RecruitingNCT06900699What this trial is testingClinicopathological Features , Outcomes and Prognostic Factors of High Risk Patients of Gestational Trophoblastic NeoplasiaWho this might be right forGestational Trophoblastic Neoplasias (GTN) Assiut University 42
Large-scale testing (Phase 3)Study completedNCT00002644What this trial is testingTamoxifen for the Prevention of Breast Cancer in High-Risk WomenWho this might be right forBreast Cancer Queen Mary University of London 7,154
Not applicableUnknownNCT04239599What this trial is testingTrial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate CancerWho this might be right forProstate Cancer Sunnybrook Health Sciences Centre 178
Not applicableUnknownNCT03672084What this trial is testingAllo-HSCT as First-line Consolidation in High-risk PTCLWho this might be right forT Cell Lymphoma Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04416516What this trial is testingSafety and Efficacy of ASN-002 Combined With a Hedgehog Pathway InhibitorWho this might be right forBasal Cell CarcinomaBasal Cell Nevus Syndrome Ascend Biopharmaceuticals Ltd 21
Not applicableUnknownNCT05601570What this trial is testingImpact of the Experience of Anaesthetists in Changing Ventilation Strategies During Panendoscopy on the Incidence of Intraoperative HypoxaemiaWho this might be right forENT Tumor Centre Hospitalier Universitaire de Besancon 850
Not applicableStudy completedNCT02618369What this trial is testingMR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and AdultsWho this might be right forOsteoid OsteomaBenign Bone TumorPain The Hospital for Sick Children 10